Novo Nordisk Pharma (Taiwan) Ltd.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.

Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards

The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.

Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards

The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.